Savara (SVRA) Change in Cash (2010 - 2026)
Savara (SVRA) reported Change in Cash of $5.6 million for Q1 2026, up 26.72% year-over-year from $4.4 million in Q1 2025, and down 66.8% quarter-over-quarter from $16.9 million in Q4 2025.
Savara (SVRA) Change in Cash (2010 - 2026) Analysis & Trends
Savara (SVRA) has 17 years of Change in Cash data on file, last reported at $5.6 million in Q1 2026.
- Change in Cash for Q1 2026 came in at $5.6 million, up 26.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.2 million (up 594.15% YoY), and the FY2025 annual result was $18.1 million, up 257.56% from the prior year.
- Change in Cash declined to $5.6 million in Q1 2026 per SVRA's latest filing, from $16.9 million in the prior quarter.
- Over five years, Change in Cash peaked at $45.2 million in Q1 2022 and troughed at -$67.7 million in Q4 2022.
- A 5-year average of $281117.6 and a median of -$1.1 million in 2023 frame the typical range for Change in Cash.
- On a YoY basis, Change in Cash climbed as much as 510.18% in 2022 and fell as far as 533.86% in 2022.
- A 5-year view of Change in Cash shows it stood at -$67.7 million in 2022, then soared by 98.37% to -$1.1 million in 2023, then slumped by 470.05% to -$6.3 million in 2024, then jumped by 368.34% to $16.9 million in 2025, then sank by 66.8% to $5.6 million in 2026.
- Business Quant data shows SVRA's Change in Cash at $5.6 million in Q1 2026, $16.9 million in Q4 2025, and -$1.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - | 5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.61 Mn |
| Dec 31, 2025 | 16.90 Mn |
| Sep 30, 2025 | -1.16 Mn |
| Jun 30, 2025 | -2.12 Mn |
| Mar 31, 2025 | 4.43 Mn |
| Dec 31, 2024 | -6.30 Mn |
| Sep 30, 2024 | -2.44 Mn |
| Jun 30, 2024 | 7.08 Mn |
| Mar 31, 2024 | -9.80 Mn |
| Dec 31, 2023 | -1.11 Mn |
| Sep 30, 2023 | 4.95 Mn |
| Jun 30, 2023 | -11.24 Mn |
| Mar 31, 2023 | -18.12 Mn |
| Dec 31, 2022 | -67.74 Mn |
| Sep 30, 2022 | 24.69 Mn |
| Jun 30, 2022 | 15.93 Mn |
| Mar 31, 2022 | 45.22 Mn |
| Dec 31, 2021 | -10.69 Mn |
| Sep 30, 2021 | 4.05 Mn |
| Jun 30, 2021 | -15.33 Mn |